12.09.2022 Ecraid partners with Valneva for a COVID-19 booster vaccine trial Ecraid has begun its first clinical trial in partnership with specialty vaccine company Valneva.
25.08.2022 Ecraid intensifies efforts against monkeypox Ecraid augments its response to the expanding monkeypox outbreak in Europe proportionate to the current perceived risk.
5.08.2022 A multi-country study of monkeypox being launched – first cases enrolled in Geneva Ecraid is part of yet another promising initiative aimed at tackling the monkeypox outbreak.
7.07.2022 European response to monkeypox virus outbreak Ecraid is assessing its readiness to respond in the event the monkeypox outbreak spreads further in Europe.
10.05.2022 Ecraid introduces new COO Nils Visser Utrecht, 10 May 2022 – The Ecraid Management Board is pleased to announce the appointment of Nils Visser as its new Chief Operat…
15.02.2022 Ecraid begins its fight against infectious diseases New foundation: The European Clinical Research Alliance for Infectious Diseases has begun.
